Last reviewed · How we verify
NCT05423873
A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging
NA trial testing Gentle Cleansing Lotion, Revision Skincare in Hyperpigmentation in 33 participants. Completed in 10 February 2022.
10 February 2022
Quick facts
| Lead sponsor | Revision Skincare |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 33 |
| Start date | 17 March 2021 |
| Primary completion | 10 February 2022 |
| Estimated completion | 10 February 2022 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Gentle Cleansing Lotion, Revision Skincare
Conditions studied
- Hyperpigmentation — all drugs for Hyperpigmentation →
- Photodamaged Skin — all drugs for Photodamaged Skin →
- Wrinkle — all drugs for Wrinkle →
- Fine Lines — all drugs for Fine Lines →
Sponsor
Revision Skincare — full company profile →
Who can join
Adults 35 to 60, female only, with Hyperpigmentation or Photodamaged Skin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This open-label, multi-center clinical trial was conducted to evaluate the dual skincare regimen of vitamin C serum and moisturizing sunscreen SPF 45 to improve facial hyperpigmentation and photodamage after 12 weeks of twice daily use in healthy female subjects between 35 - 60 years old. A total of 33 subjects completed study participation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Antioxidant Skincare Treatment for Hyperpigmented and Photodamaged Skin: Multi-Center, Open-Label, Cross-Seasonal Case Study.
Hooper D, Tedaldi R, Iglesia S, Young MB, et al · · 2023 · cited 1× · PMID 37915337
Verify or expand the search:
- PubMed search for NCT05423873
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Gentle Cleansing Lotion, Revision Skincare
Trials testing the same drug.
- NCT04911374 — An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream · NA · completed
Other recruiting trials for Hyperpigmentation
Currently open trials in the same condition.
- NCT07162623 — Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on · NA · active not recruiting
- NCT07067879 — The Effectiveness of a Novel Lip Product Containing Caulerpa Lentillifera Extract for Reducing Lip Hyperpigmentation · NA · recruiting
- NCT06349447 — Pilot Study of LED for PIE and PIH · NA · recruiting
- NCT07067515 — Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival Hyperpigmentation · Phase 1, PHASE2 · active not recruiting
Other Revision Skincare trials
Trials by the same sponsor.
- NCT07468175 — A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation · NA · completed
- NCT07501000 — Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen · NA · completed
- NCT07500623 — Efficacy and Tolerability of a Scalp Serum · NA · completed
- NCT06366503 — Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative · NA · completed
- NCT06633731 — Clinical Case Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment on Healthy Females with Fitzp · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05423873 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Revision Skincare
- Last refreshed: 21 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05423873.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing